Rhaeos Revenue and Competitors
Estimated Revenue & Valuation
- Rhaeos's estimated annual revenue is currently $9.5M per year.
- Rhaeos's estimated revenue per employee is $307,677
- Rhaeos's total funding is $13M.
Employee Data
- Rhaeos has 31 Employees.
- Rhaeos grew their employee count by 11% last year.
Rhaeos's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Commercial Strategy | Reveal Email/Phone |
3 | Chief Innovation Officer | Reveal Email/Phone |
4 | Chief Technical Officer | Reveal Email/Phone |
5 | Senior Director Neurosurgery Research | Reveal Email/Phone |
6 | Research And Development Engineer | Reveal Email/Phone |
7 | Fractional CFO | Reveal Email/Phone |
8 | Engineer | Reveal Email/Phone |
9 | Product Development Engineer | Reveal Email/Phone |
10 | Senior R&D Engineer | Reveal Email/Phone |
Rhaeos Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $58.5M | 233 | -8% | N/A | N/A |
#2 | $16.6M | 66 | 10% | N/A | N/A |
#3 | $9.8M | 39 | 0% | N/A | N/A |
#4 | $1.8M | 7 | -61% | N/A | N/A |
#5 | $19.6M | 78 | -7% | N/A | N/A |
#6 | $36.6M | 146 | -5% | N/A | N/A |
#7 | $119.7M | 477 | 5% | N/A | N/A |
#8 | $54M | 215 | 17% | N/A | N/A |
#9 | $12450M | 46985 | 1% | $1.7B | N/A |
#10 | $5.3M | 21 | -60% | N/A | N/A |
What Is Rhaeos?
Rhaeos is the world's first wearable ventricular shunt monitor.
keywords:N/A$13M
Total Funding
31
Number of Employees
$9.5M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Rhaeos News
2022-04-06 - Rhaeos, Inc. Announces Issuance of Patents Covering a New ...
Rhaeos, Inc. Announces Issuance of Patents Covering a New Family of Wearable Sensors for Non-Invasive Fluid Flow Monitoring...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.6M | 31 | 11% | N/A |
#2 | $6.2M | 31 | 11% | N/A |
#3 | $7.4M | 32 | 0% | N/A |
#4 | $4.2M | 32 | 3% | N/A |
#5 | $8.3M | 32 | -3% | N/A |